Stiff-person syndrome: What we know about Céline Dion’s rare condition – National | 24CA News

Health
Published 08.12.2022
Stiff-person syndrome: What we know about Céline Dion’s rare condition – National | 24CA News

Legendary Canadian singer Céline Dion was lately identified with a uncommon neurological dysfunction known as stiff-person syndrome (SPS) that led her to reschedule a number of European tour dates.

In two movies posted on social media on Thursday, Dion expressed that the situation isn’t permitting her “to sing the way I’m used to.”

Read extra:

Céline Dion reveals prognosis of uncommon neurological illness: ‘It’s been actually troublesome for me’

According to the National Center for Advancing Translational Sciences, there are fewer than 5,000 recognized circumstances of stiff-person syndrome within the U.S. The signs of the dysfunction can start at any level in a affected person’s life. However, it’s mostly seen in maturity.

What is stiff-person syndrome?

According to The Stiff Person Syndrome Research Foundation web site, this situation is an incurable dysfunction that causes progressive muscle rigidity and spasms. Those identified with the dysfunction will be disabled, bedridden or unable to look after themselves.

Story continues beneath commercial

The reason for this extraordinarily uncommon illness remains to be unknown, in keeping with the Yale Medicine web site, “but researchers suspect that it may be the result of an autoimmune reaction where the body attacks nerve cells in the central nervous system that control muscle movement.”

The title doesn’t do justice to the ache and life-changing signs the syndrome causes, Tara Zier, founding father of the Stiff Person Syndrome Research Foundation, advised The Canadian Press on Thursday.

“A lot of people have challenges with mobility. Many have assisted devices for mobility, walkers, wheelchairs. Some people are bedridden,” she stated.


Click to play video: 'Dementia on the rise in Canada, Ontario borrows from European treatment models'


Dementia on the rise in Canada, Ontario borrows from European therapy fashions


The Stiff Person Syndrome Research Foundation says, “the most common symptoms of SPS are muscle rigidity, stiffness and spasms in the muscles of the trunk including the back and limbs.”

Story continues beneath commercial

These will be triggered by environmental stimuli, like loud noises, or emotional stress in keeping with Yale Medicine.

“The muscle spasms can be so severe they cause the person to fall down. The muscles gradually relax after the stimulus is gone,” the Yale Medicine web site states.

About one or two individuals in one million are affected by SPS, in keeping with the Stiff Person Syndrome Center at Johns Hopkins Medicine.

Although that’s the speed that’s typically reported, researchers don’t know for certain, Dr. Marinos Dalakas, director of the neuromuscular division on the Thomas Jefferson School of Medicine in Philadelphia, advised The Canadian Press on Friday.

Read extra:

Oversight committee guidelines out mysterious mind illness in New Brunswick

Story continues beneath commercial

The variety of circumstances involving the uncommon illness might be larger as a result of individuals are so usually misdiagnosed, stated Dalakas, who can be a member of the medical advisory board for The Stiff Person Syndrome Research Foundation.

Common misdiagnoses embody Parkinson’s illness, a number of sclerosis and psychiatric problems, he stated.

How lengthy does it take to diagnose SPS?

The situation takes, on common, 5 to seven years to diagnose, in keeping with the Stiff Person Syndrome Research Foundation.

“Since it is so rare, very often it is not recognized by medical providers. Neurologists, especially movement disorder neurologists, neuromuscular neurologists, and neuro immunologists are the usual SPS experts,” stated the muse on their web site.

Yale Medicine says that “reaching a diagnosis for Stiff Person Syndrome can be difficult” and a complete examination of the sufferers takes place so as to verify the prognosis, like doing blood checks and spinal fluid evaluation.

Story continues beneath commercial


Click to play video: 'New initiative for early rehabilitation for neurological patients'


New initiative for early rehabilitation for neurological sufferers


“When conducting those tests, your doctor is looking for elevated levels of anti-glutamic acid decarboxylase (GAD) antibodies,” their web site states.

Yale Medicine explains that the immune system in a affected person who could have stiff-person syndrome “seems to attack a protein called glutamic acid decarboxylase (GAD), which helps make a substance called gamma-aminobutyric acid (GABA).”

“GABA helps regulate motor neurons by decreasing their activity,” it provides.

Low ranges of GABA could cause these neurons to fireside repeatedly even after they’re not alleged to, in keeping with Yale Medicine.

“About 60-80 percent of Stiff Person Syndrome patients have anti-GAD antibodies in their blood,” it says.

Are there therapies or a treatment?

According to Yale and the muse, there isn’t a treatment for Stiff Person Syndrome.

Story continues beneath commercial

When docs deal with sufferers with this situation, Yale Medicine says they concentrate on managing the signs with drugs “such as sedatives, muscle relaxants, and steroids.”

Medications have to be tailor-made to every affected person, relying on their signs, Dr. Marinos Dalakas, director of the neuromuscular division on the Thomas Jefferson School of Medicine in Philadelphia, advised The Canadian Press.

Read extra:

Experimental Alzheimer’s drug slows illness, researchers say. Will it make a distinction?

Commonly prescribed therapies for stiff individual syndrome embody diazepam, which might each assist relieve muscle spasms and cut back extreme anxiousness, in addition to muscle relaxants and anti-seizure drugs like gabapentin.

Specialists may additionally do a bodily examination of the muscle mass or use electromyography (EMG) to evaluate muscle and neurological operate.

Dalakas stated the sooner sufferers are identified and handled, the higher their outcomes are typically.

— With information from Global News’ Sarah Do Couto and The Canadian Press

&copy 2022 Global News, a division of Corus Entertainment Inc.